Biobrane dressing for paediatric burns in Singapore: a retrospective review

<p><b>INTRODUCTION</b>The ideal burn dressing for children should aim to alleviate pain, decrease length of hospital stay and minimise complications such as conversion and infection. The current literature is still inconclusive with regard to the gold standard burn dressing for the paediatric population.</p><p><b>METHODS</b>We retrospectively reviewed children with superficial partial thickness burns admitted to our paediatric burns unit from January 2014 to April 2015. A total of 30 patients were included in our study, of whom 13 had Biobrane dressing. The remaining 17 patients were treated with conventional silver foam dressing (i.e. Biatain Ag) and served as matched controls. Long-term follow-up scar evaluation was carried out at an average interval of two years after injury.</p><p><b>RESULTS</b>In the Biobrane group, the length of hospital stay was significantly shorter (Biobrane vs. silver foam: 4.76 ± 2.64 days vs. 8.88 ± 5.09 days; p = 0.01) and the infection rate was significantly lower (Biobrane vs. silver foam: 0% vs. 35.3%; p = 0.02). The Biobrane group had no hypergranulation or wound infection and did not require skin grafting. Long-term follow-up scar evaluation did not reveal any statistical difference between the patient groups at the two-year interval.</p><p><b>CONCLUSION</b>Paediatric patients with partial thickness burns treated with Biobrane dressing had shorter hospital stay and lower incidence of infection compared to those treated with conventional silver foam dressing. Biobrane and silver foam dressings did not demonstrate any significant difference in terms of long-term scar outcomes over an average follow-up duration of two years.</p>

Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects

Abstract Oral mucosa has been highlighted as a suitable source of epidermal cells due to its intrinsic characteristics such as its higher proliferation rate and its obtainability. Diabetic ulcers have a worldwide prevalence that is variable (1%-11%), meanwhile treatment of this has been proven ineffective. Tissue-engineered skin plays an important role in wound care focusing on strategies such autologous dermal-epidermal substitutes. Objective The aim of this study was to obtain autologous dermal-epidermal skin substitutes from oral mucosa from diabetic subjects as a first step towards a possible clinical application for cases of diabetic foot. Material and Methods Oral mucosa was obtained from diabetic and healthy subjects (n=20 per group). Epidermal cells were isolated and cultured using autologous fibrin to develop dermal-epidermal in vitro substitutes by the air-liquid technique with autologous human serum as a supplement media. Substitutes were immunocharacterized with collagen IV and cytokeratin 5-14 as specific markers. A Student´s t- test was performed to assess the differences between both groups. Results It was possible to isolate epidermal cells from the oral mucosa of diabetic and healthy subjects and develop autologous dermal-epidermal skin substitutes using autologous serum as a supplement. Differences in the expression of specific markers were observed and the cytokeratin 5-14 expression was lower in the diabetic substitutes, and the collagen IV expression was higher in the diabetic substitutes when compared with the healthy group, showing a significant difference. Conclusion Cells from oral mucosa could be an alternative and less invasive source for skin substitutes and wound healing. A difference in collagen production of diabetic cells suggests diabetic substitutes could improve diabetic wound healing. More research is needed to determine the crosstalk between components of these skin substitutes and damaged tissues.

Sustitutos cutáneos bioingenierizados para el tratamiento de heridas cutáneas difíciles de curar / Cutaneous substitutes for cutaneous lesions which are unresponsive to conventional treatment

Existe un aumento significativo de heridas cutáneas que no curan con terapias convencionales, situación preocupante tanto para la salud pública como para la economía mundial. Como posible solución se encuentra la ingeniería tisular cuyo fin es, mediante la generación de sustitutos cutáneos, entregar elementos capaces de reemplazar in vivo tejidos dañados, estimulando además la capacidad regenerativa intrínseca del paciente. Algunos productos han sido aprobados por la FDA (food and drug administration), los que han demostrado el cierre completo de heridas cutáneas refractarias a tratamientos habituales. De esta manera, la ingeniería tisular se considera actualmente como una alternativa terapéutica eficaz tanto para la cura de heridas cutáneas agudas como para heridas cutáneas crónicas, obteniéndose un balance costo-beneficio favorable a largo plazo para el paciente.

In recent years there has been a significant increase in skin lesions which do not heal with conventional therapies. This is a worrisome situation for both public health and global economy. One possible solution is tissue engineering which goal, is to generate substitute tissues that could be used to replace damaged ones in vivo, stimulating the patient’s intrinsic healing capacity. Some products have already been approved by the FDA (the Food and Drug Administration), and have already demonstrated complete closure of cutaneous lesions which are unresponsive to conventional treatment. Tissue engineering is considered an effective alternative therapy for acute and chronic lesions, and offer a favorable cost-benefit relationship in the long term.

Sustitutos cutáneos desarrollados por ingeniería de tejidos / Skin substitutes developed by tissue engineering

La piel es un tejido complejo vulnerable a procesos que alteran su estructura, integridad y funcionalidad como, por ejemplo, quemaduras, heridas crónicas y diversas enfermedades congénitas. Los avances tecnológicos en la fabricación de biomateriales y en el cultivo de células han permitido la producción de sustitutos cutáneos que han sido una alternativa terapéutica para algunas de estas complicaciones. Esta revisión pretende actualizar los aspectos generales, composición, perspectivas futuras y de aplicación de los principales sustitutos cutáneos que se ofrecen actualmente en el mercado internacional. Igualmente, presentará algunas experiencias del Grupo de Ingeniería de Tejidos y Terapias Celulares (GITTC) de la Facultad de Medicina de la Universidad de Antioquia.

The skin is a complex tissue vulnerable to different processes that may alter its structure, integrity and functionality, among them: burns, chronic wounds and various congenital diseases. Technological advances in biomaterials manufacture and cell culture have allowed the production of skin substitutes thus providing an alternative therapy for some of these complications. This review aims to update the general aspects, composition, future prospects and implementation of the most common skin substitutes currently available in the international market. Some experiences of the Tissue Engineering and Cellular Therapy Group (GITTC), at the University of Antioquia, Faculty of Medicine, in Medellín, Colombia, are also presented.

Sustitutos dérmicos definidos / Dermal substitutes defined

Son muchas las patologías que producen defectos de piel. El método de elección para la cobertura cutánea de estos defectos es el injerto de piel parcial, sin embargo, en algunos casos sus resultados no son adecuados. Los sustitutos dérmicos son una alternativa de cobertura cutánea, que existen en la actualidad y que permiten obtener mejores resultados funcionales y estéticos. Existen muchos sustitutos dérmicos en el mercado, cada uno con distintas características, beneficios y complicaciones. Esta revisión logra agrupar los aspectos más relevantes de los sustitutos dérmicos para poder tener una base teórica sobre estos productos que son de gran ayuda para poder tratar a pacientes con distintas patologías.

Many are the pathologies that cause skin defects. The gold standard for skin coverage of these defects is the partial skin graft, but in some cases the results are not appropiate. Dermal substitutes are an alternative for skin coverage that exists today and allow get better functional and aesthetic results. There are many dermal substitutes in the pharmaceutical industry, each one with different characteristics, benefits and complications. This review brings together the most important aspects of dermal substitutes to have a theoretical background on these products that are helpful to treat patients with different pathologies.

Application of Newly Developed Acellular Dermal Matrix Allograft (CG DermTM) in Breast Reconstruction with the Implant: The Prospective Study

Several freeze-dried human acellular dermal matrix have been introduced and they helped to facilitate implant based breast reconstruction by providing support to the breast lower pole, firm fixation of inframammary fold, and simple operation procedure. We evaluated clinical outcomes of recently produced human acellular dermal matrix, CG Derm(TM), prospectively. CG Derm(TM) was used in six patients and eight breasts for implant breast reconstruction. Complete blood cell count test, rountine chemisty(including ESR) test, and CRP test were performed before and after the surgery. Postoperative complication was evaluated including infection, seroma, implant malpostion, rippling deformity, and capsular contracture. Randomly selected two patients underwent breast MRI after reconstruction. Finally we examine patients' satisfaction survey and plastic surgeons' evaluation. Satisfactory breast lower pole fullness, symmetric inframammary folds and breast shapes were achieved in most patients. Overall, patients had sufficient aesthetic satisfaction and surgeon's evaluation was also good. There was no major complication except four cases of seroma which healed with conservative management. Implant breast reconstruction using CG Derm(TM) was safe and obtain good aesthetic results. But further and larger scale study should be performed to reveal out the relatively high risk of seroma.

Contractura axilar por quemadura tratada con Integra® / Axillary burn contracture treated with Integra®

Introduction: Severe axillary burn is an unusual accident that frequently evolves to contracture generating important cosmetic and functional deficiencies. Contracture scars in this region are difficult to treat because of the anatomic characteristics of the area that has multiple power vectors. Functional restoration has to be one of the main goals in the management of burns in the axilla and flaps have shown high rate of morbidity. Integra® provides satisfactory elasticity and dermal resistance which results in positive functional results. Objective: Analyze the results of the use of Integra® in axillary burn contracture scars at a specialized Burns Center. Materials and Methods: There were 4 patients who underwent reconstructive surgery using Integra® for axillary burn contractures between January 2002 and March 2006. Follow-up was divided into perioperative and late. Early follow-up checked general post-operative evolution and late follow-up was focused on functionality and patient independence evaluated using Barthel's index of daily living activities. Results: There were 3 males and 1 female, average age 27 (18-41) with a minimum follow up of 9 months. There were no perioperative complications and good or very good range of motion results. Conclusions: Our results are similar to artificial skin substitutes used in other anatomical regions.

Las quemaduras axilares severas son un accidente infrecuente que evolucionan a la retracción generando deficiencias cosméticas y funcionales. Estas cicatrices son difíciles de tratar por las características anatómicas del área, donde la corrección de un vector de movimiento puede alterar otro. Objetivo: Mostrar nuestros resultados utilizando el sustituto cutáneo Integra® en el tratamiento de cicatrices retráctiles axilares por quemadura. Pacientes y Métodos: Se recolectaron antecedentes médicos y fotográficos de pacientes portadores de cicatrices retráctiles axilares por quemadura entre enero de 2002 y marzo de 2006 en el Hospital del Trabajador de Santiago. Se evaluó pre y postoperatoriamente a los pacientes en forma subjetiva por fisiatra y con el Test de Barthel. Resultados: Se incluyeron 4 pacientes en el estudio (3 mujeres y 1 hombre), edad media 27 años (18-41). Todas las quemaduras fueron producidas por fuego. Índice de Barthel preoperatorio fue de 87,5 (levemente dependiente para las actividades de la vida diaria) y rango de movimiento moderadamente afectado. En el postoperatorio los pacientes fueron catalogados como independientes según el Test de Barthel y el rango de movimiento fue descrito como bueno o muy bueno por el fisiatra. No hubo complicaciones peri operatorias, Integra® prendió adecuadamente en todos los casos. Los pacientes fueron seguidos en promedio 16 meses (9-22). Conclusiones: Los sustitutos dérmicos han sido usados para la corrección de cicatrices de quemaduras con buenos resultados, pero no hay reportes en la axila. El pequeño número de pacientes que presentamos tienen un excelente resultado funcional, lo que nos estimula a seguir trabajando en este rumbo.

Tissue-engineered human living skin substitutes: development and clinical application

The skin acts as a barrier to exogenous substances, pathogens, and trauma. Skin defects caused by burns, venous ulcer, diabetic ulcer, or acute injury occasionally induce life-threatening situations. Tissue engineering provides an alternative for autologous or allogeneic tissue transplantation, which is required because of donor site limitations and the risks of transmitting infection. Currently, skin substitutes are made of only extracellular matrix, mainly cells, or combination of cells and matrices. New biotechnological approaches have led to the development of the skin equivalent, the closest match yet to native human skin in terms of histological and functional properties. This review article focuses upon the development of the in vitro and in vivo epidermis and dermis and their clinical applications.